Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Squamous Cell Carcinoma

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

404 public trials 130 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Completed

A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors

NCT06549816

Conditions: Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +44 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

NCT07236320

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Sichuan Cancer Hospital and Institute Chengdu, Sichuan, China

View Trial Details

Completed

PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy

NCT06192212

Conditions: Anastomotic Leak, Carcinoma, Carcinoma, Squamous Cell, +16 more
Locations: Army Medical Center of the People's Liberation Army Chongqing, Chongqing Municipality, China

View Trial Details

Completed

A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea

NCT07201571

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy

NCT06333665

Conditions: Carcinoma, Carcinoma, Squamous Cell, Diabetes Mellitus, +21 more
Locations: Army Medical Center of the People's Liberation Army Chongqing, Chongqing Municipality, China

View Trial Details

Completed

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

NCT05104567

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +29 more
Locations: City of Hope Site Number : 8400007 Duarte, California, United States

AdventHealth Orlando Site Number : 8400005 Orlando, Florida, United States

Seattle Cancer Care Alliance Site Number : 8400009 Seattle, Washington, United States

Investigational Site Number : 0560002 Brussels, Belgium

View all 29 locations

View Trial Details

Completed

Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features

NCT07181850

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University Huai'an, Jiangsu, China

View Trial Details

Completed

PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer

NCT05880082

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Army Medical Center of the People's Liberation Army Chongqing, Chongqing Municipality, China

View Trial Details

Completed

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

NCT03708328

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +35 more
Locations: Columbia Univ Med Ctr New York, United States

MD Anderson Cancer Center Houston, Texas, United States

Herlev Hospital Herlev, Denmark

Rigshospitalet København Ø, Denmark

View all 17 locations

View Trial Details

Completed

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

NCT03783442

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Smilow Cancer Hospital At Yale New Haven, Connecticut, United States

Renovatio Clinical The Woodlands, Texas, United States

Coffs Harbour Base Hospital Coffs Harbour, New South Wales, Australia

St Vincents Hospital Melbourne Fitzroy, Victoria, Australia

View all 124 locations

View Trial Details